(IBTM) iShares iBonds Dec 2032 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E2963 • Target Maturity
IBTM: U.S., Treasury, Securities, ETF, Bonds
The iShares iBonds Dec2032 Term Treasury ETF (NASDAQ:IBTM) is designed to track a market value-weighted index of U.S. Treasury securities, with the weighting adjusted to account for the amounts held by the Federal Reserves System Open Market Account (SOMA). This means that the funds holdings are concentrated in Treasury securities with a maturity date in December 2032, providing investors with a targeted exposure to a specific segment of the yield curve.
The funds investment strategy is to invest at least 80% of its assets in the component securities of the underlying index, and at least 90% of its assets in U.S. Treasury securities that are expected to help the fund track the index. This approach is designed to minimize tracking error and ensure that the funds returns are closely aligned with the performance of the underlying index, except during the final months of the funds operations when the portfolio may be adjusted to prepare for liquidation.
Given the current market conditions and the funds technical profile, it appears that IBTM is trading near its 20-day simple moving average (SMA20) of $22.74, with a relatively low average true range (ATR) of 0.19, indicating a stable trading environment. The funds price is also above its 200-day simple moving average (SMA200) of $22.41, suggesting a longer-term uptrend. With a relatively stable yield curve and expectations of continued demand for U.S. Treasury securities, it is likely that IBTM will continue to trade within a narrow range, potentially between $22.50 and $23.00, over the next few weeks.
Based on the available technical and fundamental data, a forecast for IBTM is that it will maintain its current price level, potentially with a slight upward bias, as the fund continues to track its underlying index and benefit from the overall stability of the U.S. Treasury market. With an AUM of $316.02M USD, the fund has a sufficient scale to maintain its operations and track the index effectively. As the maturity date approaches, investors can expect the funds holdings to become more concentrated in a specific maturity segment, potentially reducing the funds duration and interest rate risk.
Additional Sources for IBTM ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBTM ETF Overview
Market Cap in USD | 317m |
Category | Target Maturity |
TER | 0.07% |
IPO / Inception | 2022-07-06 |
IBTM ETF Ratings
Growth Rating | 16.2 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -7.68 |
Analysts | - |
Fair Price Momentum | 20.89 USD |
Fair Price DCF | - |
IBTM Dividends
No Dividends PaidIBTM Growth Ratios
Growth Correlation 3m | 37.4% |
Growth Correlation 12m | 40.9% |
Growth Correlation 5y | 39.4% |
CAGR 5y | 0.34% |
CAGR/Max DD 5y | 0.03 |
Sharpe Ratio 12m | -0.47 |
Alpha | 0.84 |
Beta | -0.072 |
Volatility | 6.34% |
Current Volume | 74.3k |
Average Volume 20d | 38.5k |
As of May 22, 2025, the stock is trading at USD 22.46 with a total of 74,324 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -0.65%, over three months by +0.89% and over the past year by +4.55%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2032 is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 16.22 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBTM as of May 2025 is 20.89. This means that IBTM is currently overvalued and has a potential downside of -6.99%.
iShares iBonds Dec 2032 has no consensus analysts rating.
According to ValueRays Forecast Model, IBTM iShares iBonds Dec 2032 will be worth about 22.6 in May 2026. The stock is currently trading at 22.46. This means that the stock has a potential upside of +0.45%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 22.6 | 0.4% |